222 related articles for article (PubMed ID: 22934689)
1. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
[TBL] [Abstract][Full Text] [Related]
2. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
[TBL] [Abstract][Full Text] [Related]
3. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
[TBL] [Abstract][Full Text] [Related]
4. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
5. [Malignancy cases in HIV-positive patients in Lodz region in years 1992-2010].
Jabłonowska E; Małolepsza E; Strycharz M; Wójcik K
Przegl Epidemiol; 2011; 65(2):339-43. PubMed ID: 21913486
[TBL] [Abstract][Full Text] [Related]
6. HIV infection and the risk of cancers with and without a known infectious cause.
Silverberg MJ; Chao C; Leyden WA; Xu L; Tang B; Horberg MA; Klein D; Quesenberry CP; Towner WJ; Abrams DI
AIDS; 2009 Nov; 23(17):2337-45. PubMed ID: 19741479
[TBL] [Abstract][Full Text] [Related]
7. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
[TBL] [Abstract][Full Text] [Related]
8. Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.
Chao C; Leyden WA; Xu L; Horberg MA; Klein D; Towner WJ; Quesenberry CP; Abrams DI; Silverberg MJ
AIDS; 2012 Nov; 26(17):2223-31. PubMed ID: 22951631
[TBL] [Abstract][Full Text] [Related]
9. Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors.
Petoumenos K; Hui E; Kumarasamy N; Kerr SJ; Choi JY; Chen YM; Merati T; Zhang F; Lim PL; Sungkanuparph S; Pujari S; Ponnampalavanar S; Ditangco R; Lee CK; Grulich A; Law MG;
J Int AIDS Soc; 2010 Dec; 13():51. PubMed ID: 21143940
[TBL] [Abstract][Full Text] [Related]
10. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
11. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA;
J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153
[TBL] [Abstract][Full Text] [Related]
12. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
13. Nationwide population-based incidence of cancer among patients with HIV/AIDS in South Korea.
Lee SO; Lee JE; Lee S; Lee SH; Kang JS; Son H; Lee H; Kim J
Sci Rep; 2022 Jun; 12(1):9974. PubMed ID: 35705675
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
15. Time trends in cancer incidence in Australian people living with HIV between 1982 and 2012.
Wong IKJ; Grulich AE; Poynten IM; Polizzotto MN; van Leeuwen MT; Amin J; McGregor S; Law M; Templeton DJ; Vajdic CM; Jin F
HIV Med; 2022 Feb; 23(2):134-145. PubMed ID: 34585487
[TBL] [Abstract][Full Text] [Related]
16. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.
Guiguet M; Boué F; Cadranel J; Lang JM; Rosenthal E; Costagliola D;
Lancet Oncol; 2009 Dec; 10(12):1152-9. PubMed ID: 19818686
[TBL] [Abstract][Full Text] [Related]
17. Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009.
Chen M; Jen I; Chen YH; Lin MW; Bhatia K; Sharp GB; Law MG; Arthur Chen YM
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):463-72. PubMed ID: 24583616
[TBL] [Abstract][Full Text] [Related]
18. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.
Crum-Cianflone N; Hullsiek KH; Marconi V; Weintrob A; Ganesan A; Barthel RV; Fraser S; Agan BK; Wegner S
AIDS; 2009 Jan; 23(1):41-50. PubMed ID: 19050385
[TBL] [Abstract][Full Text] [Related]
19. Trends in cancer diagnoses and survival among persons with AIDS in a high HIV prevalence urban area.
Castel AD; Young H; Akiwumi AM; Vargas A; Rogers K; West T; Levine PH
AIDS Care; 2015; 27(7):860-9. PubMed ID: 25714364
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of cancer risk late after AIDS onset in the United States.
Simard EP; Pfeiffer RM; Engels EA
Arch Intern Med; 2010 Aug; 170(15):1337-45. PubMed ID: 20696958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
